strides pharma science
Jump to
82 Results Found
  • Strides Pharma Science arm gets USFDA nod for pain relieving drug Feb 24, 2021 12:13 PM IST

    Strides Pharma Science arm gets USFDA nod for pain relieving drug

    The approved product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Children's Motrin Oral Suspension, 100 mg/mL, of Johnson & Johnson Consumer Inc.

  • Strides Pharma Science receives USFDA approval for Prednisone tablets Feb 12, 2021 11:27 AM IST

    Strides Pharma Science receives USFDA approval for Prednisone tablets

    The approved product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD) Deltasone tablets, 10 mg and 20 mg, of Pharmacia and Upjohn Co.

  • Buy Strides Pharma Science; target of Rs 1020: Sharekhan Feb 09, 2021 10:33 PM IST

    Buy Strides Pharma Science; target of Rs 1020: Sharekhan

    Sharekhan is bullish on Strides Pharma Science has recommended buy rating on the stock with a target price of Rs 1020 in its research report dated February 04, 2021.

  • Strides Pharma  Consolidated December 2020 Net Sales at Rs 832.02 crore, up 13.6% Y-o-Y Feb 05, 2021 10:22 AM IST

    Strides Pharma Consolidated December 2020 Net Sales at Rs 832.02 crore, up 13.6% Y-o-Y

  • Strides Pharma  Standalone December 2020 Net Sales at Rs 421.09 crore, up 15.53% Y-o-Y Feb 05, 2021 09:11 AM IST

    Strides Pharma Standalone December 2020 Net Sales at Rs 421.09 crore, up 15.53% Y-o-Y

  • Strides Pharma  Standalone December 2020 Net Sales at Rs 421.09 crore, up 15.53% Y-o-Y Feb 04, 2021 09:00 PM IST

    Strides Pharma Standalone December 2020 Net Sales at Rs 421.09 crore, up 15.53% Y-o-Y

  • Strides Pharma  Consolidated December 2020 Net Sales at Rs 832.02 crore, up 13.6% Y-o-Y Feb 04, 2021 09:00 PM IST

    Strides Pharma Consolidated December 2020 Net Sales at Rs 832.02 crore, up 13.6% Y-o-Y

  • Strides Pharma Science gets USFDA nod for generic drug Jan 25, 2021 01:58 PM IST

    Strides Pharma Science gets USFDA nod for generic drug

    The company's product is bioequivalent and therapeutically equivalent to Allergan Sales' Actigall capsules, Strides Pharma Science added.

  • Buy Strides Pharma Science: target of Rs 980 : Sharekhan Dec 11, 2020 02:06 PM IST

    Buy Strides Pharma Science: target of Rs 980 : Sharekhan

    Sharekhan is bullish on Strides Pharma Science has recommended buy rating on the stock with a target price of Rs 980 in its research report dated December 10, 2020.

  • Strides Pharma gets USFDA nod for Prednisone; shares down nearly 3% Nov 23, 2020 01:13 PM IST

    Strides Pharma gets USFDA nod for Prednisone; shares down nearly 3%

    The company has 127 cumulative ANDA filings with USFDA of which 93 ANDAs have been approved and 34 are pending approval.

  • Strides Pharma  Consolidated September 2020 Net Sales at Rs 793.56 crore, up 10.97% Y-o-Y Nov 02, 2020 06:33 PM IST

    Strides Pharma Consolidated September 2020 Net Sales at Rs 793.56 crore, up 10.97% Y-o-Y

  • Strides Pharma  Consolidated September 2020 Net Sales at Rs 793.56 crore, up 10.97% Y-o-Y Oct 30, 2020 09:25 AM IST

    Strides Pharma Consolidated September 2020 Net Sales at Rs 793.56 crore, up 10.97% Y-o-Y

  • Strides Pharma  Standalone September 2020 Net Sales at Rs 384.33 crore, down 9.66% Y-o-Y Oct 30, 2020 09:11 AM IST

    Strides Pharma Standalone September 2020 Net Sales at Rs 384.33 crore, down 9.66% Y-o-Y

  • Strides Pharma Science Q2 profit falls 46% to Rs 77 crore Oct 29, 2020 04:04 PM IST

    Strides Pharma Science Q2 profit falls 46% to Rs 77 crore

    The company had posted a net profit of Rs 141.90 crore for the corresponding period of the previous fiscal, Strides Pharma said in a filing to BSE.

  • Strides receives USFDA approval for Ethacrynic Acid Tablets Oct 20, 2020 11:40 AM IST

    Strides receives USFDA approval for Ethacrynic Acid Tablets

    The product is a generic version of Edecrin Tablets, 25 mg, of Bausch Health Americas, Inc., the company said in a statement.

  • Strides Pharma Science shares up 3% as subsidiary gets USFDA nod Sep 22, 2020 12:51 PM IST

    Strides Pharma Science shares up 3% as subsidiary gets USFDA nod

    Singapore-based Strides Pharma Global Pte Ltd has received approval from the US health regulator for Butalbital, Acetaminophen, and Caffeine tablets, used to treat tension headaches.

  • Societe Generale buys 0.7% stake in Strides Pharma, Mayfield XII Mauritius offloads 4.8% shares in Tejas Networks Sep 08, 2020 10:57 PM IST

    Societe Generale buys 0.7% stake in Strides Pharma, Mayfield XII Mauritius offloads 4.8% shares in Tejas Networks

    Societe Generale bought 6,26,279 shares in the pharma company at Rs 612 per share

  • Buy Strides Pharma Science: target of Rs 710: ICICI Securities Sep 04, 2020 08:35 PM IST

    Buy Strides Pharma Science: target of Rs 710: ICICI Securities

    ICICI Securities is bullish on Strides Pharma Science recommended buy rating on the stock with a target price of Rs 710 in its research report dated September 03, 2020.

  • Accumulate Strides Pharma Science; target of Rs 621: Geojit Aug 09, 2020 09:00 AM IST

    Accumulate Strides Pharma Science; target of Rs 621: Geojit

    Geojit recommended accumulate rating on Strides Pharma Science with a target price of Rs 621 in its research report dated August 07, 2020.

  • Strides Pharma Science Q1 net profit jumps over 4-fold to Rs 102 crore Aug 05, 2020 07:45 PM IST

    Strides Pharma Science Q1 net profit jumps over 4-fold to Rs 102 crore

    The company had posted a net profit of Rs 25.36 crore in the corresponding period of the previous fiscal, Strides Pharma Science said in a filing to the BSE.

  • Strides Pharma  Consolidated June 2020 Net Sales at Rs 781.80 crore, up 14% Y-o-Y Aug 05, 2020 07:11 PM IST

    Strides Pharma Consolidated June 2020 Net Sales at Rs 781.80 crore, up 14% Y-o-Y

  • Strides Pharma  Standalone June 2020 Net Sales at Rs 409.34 crore, down 7.5% Y-o-Y Aug 05, 2020 07:11 PM IST

    Strides Pharma Standalone June 2020 Net Sales at Rs 409.34 crore, down 7.5% Y-o-Y

  • Strides Pharma share price gains on USFDA approval Jul 09, 2020 09:41 AM IST

    Strides Pharma share price gains on USFDA approval

    The company has 124 cumulative ANDA filings with USFDA, of which 87 have been approved and 37 are waiting approval.

  • Promoter Participaciones acquires 1.38% stake in Mahindra CIE, Lifecell offloads 1.07% in Strides Pharma Jun 23, 2020 09:44 PM IST

    Promoter Participaciones acquires 1.38% stake in Mahindra CIE, Lifecell offloads 1.07% in Strides Pharma

    Beacon Trusteeship sold 5,57,271 shares (representing 0.69 percent of total paid up equity capital) in Tourism Finance Corporation at Rs 37.65 per share

  • Strides Pharma Science gains 5% on USFDA nod for skin ointment Jun 02, 2020 01:46 PM IST

    Strides Pharma Science gains 5% on USFDA nod for skin ointment

    According to IQVIA MAT data, the US market for Triamcinolone Acetonide Ointment is approximately $15 million.

Sections